摘要
目的研究γ-分泌酶抑制剂DAPT对哮喘气道炎症、气道高反应和Th17/Treg失衡的干预作用,为其抗哮喘活性制剂的研究与开发提供理论依据。方法 6-8周雌性C57BL/6小鼠45只被随机分为对照组,哮喘组和DAPT组,每组15只苏木精-伊红(HE)染色法观察气道病理改变,酶联免疫吸附法检测小鼠支气管肺泡灌洗液(BALF)中细胞因子和炎性介质的水平,逆转录聚合酶链反应法(RT-PCR)分析脾脏Foxp3 mRNA的表达。结果 DAPT组较哮喘组气道炎症明显减轻,气道内黏液分泌显著减少。哮喘组IgE、IL-17、IL-10和TGF-β1的含量分别为(695±148)ng/ml,(58±6)pg/ml,(148±12)pg/ml,(18±3)pg/ml;DAPT组IgE、IL-17、IL-10和TGF-β1的含量分别为(486±152)ng/ml,(27±6)pg/ml,(193±17)pg/ml,(33±5)pg/ml。与哮喘组比较,DAPT组气道灌洗液中IL-17、IgE水平显著降低(P<0.01),IL-10、TGF-β1水平显著增加(P<0.01),Foxp3 mRNA的表达也显著增加(P<0.01)。结论γ-分泌酶抑制剂DAPT具有抗哮喘小鼠Th17/Treg失衡的作用。
Objective To explore the effects of γ-secretase inhibitor( DAPT) on the airway inflammation,the airway hyperactivity and the imbalance of Th17/Treg in a mouse model of allergic asthma for providing a theoretical basis for the research and development of anti-asthma activity preparations. Methods Forty-five female C57BL/6 mice were randomly divided into 3 groups: control group,asthma group and DAPT group. The pathological changes of lung tissue were analyzed by hematoxylin-eosin staining. Levels of cytokine and inflammatory mediators in bronchoalveolar lavage fluid( BALF) were measured by enzyme-linked immunosorbent assay. The expression of Foxp3 mRNA in spleen was detected by reverse transcription polymerase chain reaction( RT-PCR). Results The airway inflammation and mucus secretion were alleviated in DAPT group compared with asthma group. The contents of IgE,IL-17,IL-10 and TGF-β1in asthma group were( 695±148) ng/ml,( 58±6) pg/ml,( 148±12) pg/ml,( 18± 3) pg/ml,respectively. The contents of IgE,IL-17,IL-10 and TGF-β1in DAPT group were( 486±152) ng/ml,( 27±6) pg/ml,( 193±17) pg/ml,( 33±5) pg/ml,respectively. Compared with asthma group,the levels of IgE and IL-17 were significantly decreased in DAPT group( P〈0. 01),the levels of IL-10,TGF-β1and the expression of Foxp3 mRNA were significantly increased in DAPT group( P〈0. 01). Conclusion The γ-secretase inhibitor DAPT may efficiently regulate the imbalance of Th17/Treg to balance a mouse asthmatic model.
作者
辛娜
李敬梅
王永锋
王瑶
陈婕
杨超
吴跃刚
XIN Na LI Jingmei WANG Yongfeng WANG Yao CHEN Jie YANG Chao WU Yuegang(Department of Clinical Laboratory, First Affiliated Hospital of Xi' an Medical University, Xi' an 710077, China Department of Respiratory Medicine, Huashan Center Hospital of Xi' an)
出处
《山西医科大学学报》
CAS
2017年第9期918-921,共4页
Journal of Shanxi Medical University
基金
陕西省教育厅专项科研计划项目(16JK1647)